Document is current
Any future updates will be listed below
-
Authors
Sarrió, Regina Gironés https://orcid.org/0000-0002-5548-0553
Benítez Fuentes, Javier David
García Samblás, Victoria https://orcid.org/0009-0002-7796-0176
Guillot Morales, Mónica https://orcid.org/0000-0001-7509-146X
Palacios Ozores, Patricia https://orcid.org/0000-0003-0410-079X
Ruiz-Casado, Ana https://orcid.org/0000-0002-7672-2638
Torres-Jiménez, Javier https://orcid.org/0000-0001-9023-4529
Vieito Villar, María https://orcid.org/0000-0001-7531-343X
,
-
Funding
Funding for this research was provided by:
The medical writing assistance was funded by unrestricted collaboration with MSD
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 5 November 2025
First Online: 10 December 2025
Declarations
:
: Javier David Benítez Fuentes has received speech and lecture fees, and travel reimbursements from MSD and BMS.Ana Ruiz-Casado has received honoraria for speaker or advisor roles from Amgen, Servier, MSD, Takeda and Medtronic.María Vieito Villar has received honoraria for speaker or advisor roles from Laminar Pharmaceuticals, Novocure and Servier and as a steering committee member from BMS. She has also been a principal investigator on projects related to BMS, Debiopharm, Enterome, Hutchinson Pharma, Novartis, Roche and Tahio and has had a leadership role on the Grupo Español de Investigación en Neurología.Regina Gironés Sarrió, Victoria García-Samblás, Mónica Guillot Morales, Patricia Palacios Ozores, and Javier Torres-Jiménez have no conflicts of interest.
: No persons or animals were involved in this review.
